Top compounds associated with response to CYP46A1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA bid1870 gCSI pan-cancer AAC -0.068 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.041 0.2
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA ML006 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.041 0.2
mRNA JW-74 CTRPv2 pan-cancer AAC 0.054 0.2
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.044 0.2
Download CSV